Mozarin Swift (Escitalopram Oxalate)

Escitalopram, the active ingredient in Mozarin Swift, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral administration. It works by increasing serotonin levels in the central nervous system and is prescribed for major depressive disorder as well as generalized, social and panic anxiety conditions in adult patients.

GNH USA supplies Mozarin Swift as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Escitalopram is used to treat disorders within the depressive and anxiety disease families by enhancing serotonergic neurotransmission.

- Major depressive disorder: reduces depressive symptoms and improves mood. - Generalized anxiety disorder: alleviates excessive worry and tension. - Social anxiety disorder: decreases fear of social situations and improves functioning. - Panic disorder: lessens frequency and severity of panic attacks.

Escitalopram may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Insomnia - Dry mouth - Sexual dysfunction - Dizziness

Serious or Rare Side Effects: - Serotonin syndrome (agitation, hyperthermia, tremor) - Suicidal thoughts or behavior, especially early in treatment - Severe allergic reaction (anaphylaxis) - QT interval prolongation - Mania or hypomania - Hyponatremia (low blood sodium)

When prescribing escitalopram, clinicians should consider several safety precautions to minimize risk.

- Assess for suicidal ideation: monitor patients, especially during early treatment. - Monitor for serotonin syndrome: watch for agitation, hyperthermia, tremor. - Use caution in hepatic impairment: dose adjustment may be required. - Avoid abrupt discontinuation: taper to reduce withdrawal symptoms. - Consider dose reduction in elderly: increased sensitivity to side effects. - Store at room temperature: keep in original packaging, protect from moisture.

Escitalopram can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: increased risk of QT prolongation. - Linezolid: additive serotonergic effect. - Tramadol: heightened serotonin activity. - St. John’s Wort: may reduce escitalopram levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding risk. - Anticoagulants (e.g., warfarin): monitor INR. - Other serotonergic agents (e.g., triptans, other SSRIs): watch for serotonin syndrome. - CYP2C19 inhibitors (e.g., fluoxetine): may raise escitalopram concentrations. - Alcohol: can enhance CNS depression.